BioNTech Founders Name New mRNA Startup Arife
Co-founders Ugur Sahin and Özlem Türeci have named their new Mainz-headquartered pharmaceutical venture Arife, confirming plans to transition out of BioNTech by late 2026. The new firm will focus on ... Read More